Medication info

B. Braun 5% Dextrose Injection

Prescription medicationInjectionsIntravenous injectionApproval withdrawn
Ingredient · strength
Glucose Monohydrate›5.5g / 100mL
Manufacturer / importer
B.Braun Korea Co., Ltd
Appearance
A colorless and transparent infusion solution filled in a polyethylene container
Packaging
100 milliliters/bottle, 500 milliliters/bottle, 1000 milliliters/bottle
Approval status
Approval withdrawn

MFDS item code 200210364 · Notified 2002.05.06

This product's status changed to Approval withdrawn on 2024.12.13. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Dissolution and dilution of injectable drugs; treatment of dehydration due to water deficiency
Who receives it
Adults
Adult administration
(Injection) (5%) ○ Adults: Administer 500∼1000 mL per dose by intravenous injection. ○ The intravenous infusion rate should not exceed 0.5 g/kg per hour, calculated as glucose. ○ Use an appropriate amount to dissolve and dilute injections. Adjust the dose as appropriate according to age and symptoms.

Ingredients

Importer
B.Braun Korea Co., Ltd

Efficacy & effects

Dissolution and dilution of injectable drugs; treatment of dehydration due to water deficiency

  • Dehydration
  • fluid deficiency
View approved original text

This medication is used to replenish fluids in cases of dehydration, particularly in conditions of fluid deficiency. It can also be used to dissolve and dilute other injectable medications, thereby helping to safely administer drugs. Therefore, it plays an important role as a fluid supplement and a diluent for injection solutions.

How it is given

Adult administration

(Injection) (5%) ○ Adults: Administer 500∼1000 mL per dose by intravenous injection. ○ The intravenous infusion rate should not exceed 0.5 g/kg per hour, calculated as glucose. ○ Use an appropriate amount to dissolve and dilute injections. Adjust the dose as appropriate according to age and symptoms.

Precautions

This medication should be handled with care when using glass ampoules. If glass fragments mix in while breaking the ampoule, it may cause harmful reactions, so extra caution should be taken, especially for children and the elderly. This medication contains glucose, which can increase the consumption of Vitamin B1 (thiamine) in the body during intravenous administration. Therefore, there is a risk of severe Vitamin B1 deficiency, and caution is needed. This medication should not be used in patients with certain conditions, such as storage dehydration, fluid overload, hyperglycemia, acidosis, hypokalemia, and glucose intolerance. It should also not be administered to patients with hypersensitivity to this drug. Patients at risk of potassium, phosphate, or magnesium deficiency, those with impaired kidney function, heart failure patients, or those with severe malnutrition should use this medication cautiously and frequently monitor their electrolyte status. Rapid or excessive administration of this medication can cause electrolyte imbalances, and there is a risk of elevated bilirubin and lactic acid levels in the blood. Additionally, side effects such as hypokalemia, hyperosmolar coma, acidosis, dehydration, and polyuria may occur. When administered intravenously, fluid overload or electrolyte imbalances, pulmonary edema, etc., may occur, so caution is advised. Patients with glucose intolerance may experience hyperglycemia and renal impairment. Prolonged use of this medication may affect insulin secretion, so insulin should be administered if necessary. Blood sugar control must be thorough in patients after surgery or trauma and in those with glucose intolerance. During administration of this medication, serum electrolyte tests, fluid balance, and blood glucose levels should be regularly monitored, as well as levels of potassium and phosphate in the blood. The safety of this medication during pregnancy is not certain; thus, it should only be used after carefully considering the risks to the fetus and the therapeutic benefits. Administration during labor may cause issues such as hyperglycemia or hypoglycemia for both the mother and the newborn. Newborns, especially preterm or low-birth-weight infants, are at a higher risk of hypoglycemia or hyperglycemia, so blood glucose should be closely monitored, as hypoglycemia can lead to serious brain damage. Elderly patients should be especially cautious when using this medication due to reduced physical functions. Excessive administration may lead to symptoms of hyperglycemia or diabetes, in which case insulin therapy may be necessary. If excessive amounts are administered subcutaneously, blood circulation issues and exacerbated local irritation may occur; therefore, this should be avoided. Unused medication should be discarded after opening. To reduce the risk of infection when administering injections, cleanliness should be maintained, and it should be warmed to body temperature if cold. Abrupt discontinuation of high-concentration solutions may cause hypoglycemia; therefore, it should be tapered off gradually. Chemical or physical reactions may occur when this medication is mixed with other drugs, so it should be used immediately after mixing, and any adverse reactions should be carefully monitored. Air entering the injection container can cause air embolism, so caution is advised to avoid air when administering continuously.

Side effects

  • Electrolyte loss
  • elevated bilirubin levels
  • elevated lactate levels
  • hypokalemia
  • hyperosmolar coma
  • acidosis
  • dehydration
  • hyperosmolality
  • polyuria
  • fluid or solute overload
Show 11 more
  • fluid electrolyte imbalance
  • congestion
  • pulmonary edema
  • hyperglycemia
  • renal loss
  • fever
  • phlebitis
  • thrombosis
  • extravasation of blood
  • injection site pain
  • uremia

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a sealed container to prevent air or moisture from entering. It should be kept away from direct sunlight and stored at room temperature that is neither too hot nor too cold.

Appearance and packaging

Appearance

A colorless and transparent infusion solution filled in a polyethylene container

Package unit

100 milliliters/bottle, 500 milliliters/bottle, 1000 milliliters/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.